Atsena Therapeutics

aid: atsena-therapeutics
name: Atsena Therapeutics
description: 'Atsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, in the Research
  Triangle, developing first- and best-in-class genetic medicines for inherited retinal diseases with the goal of reversing
  or preventing blindness. Founded by ocular gene therapy pioneers Shannon Boye and Sanford Boye, the company builds on two
  proprietary AAV delivery platforms: a laterally spreading AAV.SPR capsid engineered to reach retinal cells without the surgical
  trauma of a subretinal bleb, and a dual-vector technology that splits genes too large for a single AAV across two vectors.
  Its clinical pipeline includes ATSN-201 for X-linked retinoschisis (XLRS) in a pivotal Phase 3 trial, ATSN-101 for LCA1
  (Leber congenital amaurosis 1) advancing to a pivotal trial with partner Nippon Shinyaku, and IND-enabling programs ATSN-301
  for Usher syndrome 1B and ATSN-401 for Stargardt disease. Atsena runs no developer program and publishes no product API,
  no developer documentation and no specification of its own. The only machine-readable surface it exposes is the anonymously
  readable WordPress REST content API behind atsenatx.com, which serves the company''s press releases, program and platform
  pages, and media library as JSON; the OpenAPI in this repo is derived by API Evangelist from that surface''s own live route
  index.'
url: https://raw.githubusercontent.com/api-evangelist/atsena-therapeutics/refs/heads/main/apis.yml
image: https://atsenatx.com/wp-content/themes/atsenatx/img/touch-icon-ipad-retina.png
x-type: company
x-source: harvest:secondary-market
x-tier: enriched
x-tier-reason: enrichment pass 2026-08-02
specificationVersion: '0.20'
created: '2026-08-02'
modified: '2026-08-02'
tags:
- Company
- Biotechnology
- Gene Therapy
- Life Sciences
- Pharmaceuticals
- Clinical Trials
- Ophthalmology
- Rare Disease
- Healthcare
- Research and Development
- Content API
- WordPress
apis:
- aid: atsena-therapeutics:atsena-therapeutics-content-api
  name: Atsena Therapeutics Content API
  description: The anonymously readable WordPress REST API behind atsenatx.com. It exposes Atsena Therapeutics press releases
    and company news (posts), the program pages for ATSN-201/XLRS, ATSN-101/LCA1, ATSN-301/USH1B and ATSN-401/Stargardt plus
    the pipeline and the two AAV platform-technology pages (pages), the media library, post categories and tags, cross-content
    search, and the type/taxonomy/status discovery endpoints. This is not a developer product Atsena markets; it is the site's
    own content surface, published at /wp-json/ and verified on 2026-08-02 to return data without credentials across all 20
    modelled operations. The OpenAPI in this repo is derived from that published route index. Writes and the privileged reads
    (users, settings, plugins, templates, menus, the wp-abilities registry) are gated behind WordPress application passwords,
    which no third party can obtain, and are deliberately not modelled.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://atsenatx.com/wp-json
  tags:
  - content
  - press-releases
  - clinical-programs
  - wordpress
  properties:
  - type: OpenAPI
    url: openapi/atsena-therapeutics-wp-rest-openapi.yml
  - type: Overlay
    url: overlays/atsena-therapeutics-wp-rest-overlay.yaml
  - type: Authentication
    url: authentication/atsena-therapeutics-authentication.yml
  - type: Conventions
    url: conventions/atsena-therapeutics-conventions.yml
  - type: ErrorCatalog
    url: errors/atsena-therapeutics-problem-types.yml
  - type: DataModel
    url: data-model/atsena-therapeutics-data-model.yml
  x-contract-provenance: Derived by the API Evangelist enrichment pipeline from the WordPress REST route index the site publishes
    at https://atsenatx.com/wp-json/ (233 routes across 12 namespaces, harvested verbatim to openapi/atsena-therapeutics-wp-rest-discovery-original.json)
    and verified against live anonymous responses on 2026-08-02. Atsena Therapeutics publishes no developer documentation,
    no API reference, no getting-started guide and no support channel for this surface, so no Documentation/APIReference/GettingStarted/DeveloperPortal
    pointers are emitted — the humanURL above is the upstream WordPress REST handbook that describes the wp/v2 contract this
    surface implements.
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://atsenatx.com/
- type: About
  url: https://atsenatx.com/about/overview/
- type: Blog
  url: https://atsenatx.com/news/
- type: News
  url: https://atsenatx.com/news/
- type: PressReleases
  url: https://atsenatx.com/news/press-releases/
- type: BlogRSS
  url: https://atsenatx.com/feed/
- type: Publications
  url: https://atsenatx.com/news/presentations-and-publications/
- type: Pipeline
  url: https://atsenatx.com/programs/pipeline/
- type: Technology
  url: https://atsenatx.com/our-approach/
- type: ClinicalTrials
  url: https://atsenatx.com/clinical-trials/
- type: Patients
  url: https://atsenatx.com/for-patients/
- type: PrivacyPolicy
  url: https://atsenatx.com/privacy-policy/
- type: Support
  url: https://atsenatx.com/contact/
- type: Contact
  url: https://atsenatx.com/contact/
- type: Careers
  url: https://atsenatx.com/careers/
- type: LinkedIn
  url: https://www.linkedin.com/company/atsenatx
- type: Investors
  url: https://atsenatx.com/about/investors/
- type: Partners
  url: https://atsenatx.com/about/partners/
- type: SecondaryMarket
  url: https://forgeglobal.com/atsena-therapeutics_stock/
- type: OpenAPI
  url: openapi/atsena-therapeutics-wp-rest-openapi.yml
- type: Overlay
  url: overlays/atsena-therapeutics-wp-rest-overlay.yaml
- type: Authentication
  url: authentication/atsena-therapeutics-authentication.yml
- type: Conventions
  url: conventions/atsena-therapeutics-conventions.yml
- type: ErrorCatalog
  url: errors/atsena-therapeutics-problem-types.yml
- type: DataModel
  url: data-model/atsena-therapeutics-data-model.yml
- type: Lifecycle
  url: lifecycle/atsena-therapeutics-lifecycle.yml
- type: Conformance
  url: conformance/atsena-therapeutics-conformance.yml
- type: WellKnown
  url: well-known/atsena-therapeutics-well-known.yml
- type: DomainSecurity
  url: security/atsena-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/atsena-therapeutics-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment-notes: 'Deliberately absent, each a verified negative probed on 2026-08-02, recorded so a later pass does not
  re-litigate them: Idempotency (no idempotency contract exists on this surface — WordPress core implements no idempotency
  key, and every modelled operation is a safe GET); SDKs and Packages (nothing first-party on npm, PyPI or any registry, and
  no GitHub organization attributable to the company); StatusPage and Deprecation (status.atsenatx.com NXDOMAIN, no policy,
  no RFC 8594 Sunset or Deprecation headers on any response); Security and SecurityTxt (/.well-known/security.txt 404, no
  disclosure page, no bug bounty — probe-security-programs.py returned vdp=none); TrustCenter and Compliance (trust.atsenatx.com
  NXDOMAIN, and the company''s own 29-page list contains no compliance, certification or state-disclosure document); AgentCard
  (/.well-known/agent-card.json and /.well-known/agent.json both 404, against a host that serves a real HTML 404 rather than
  an SPA catch-all 200, so this is a true negative); MCPServer and ToolCrosswalk (no mcp namespace among the 12 registered,
  /.well-known/mcp.json 404 — note the wp-abilities/v1 registry IS installed but returns 401 anonymously, so no tool list
  is readable); AsyncAPI and Webhooks (no event, streaming or webhook surface of any kind); OAuthScopes (no OAuth — /.well-known/oauth-authorization-server
  and /.well-known/oauth-protected-resource both 404, so there is no scope surface to record); ContentSignal (robots.txt is
  a bare Yoast block allowing everything, with no Content Signals Policy, no AI-preference directives and no named AI-crawler
  rules — captured verbatim as evidence in well-known/ but not claimed as a signal); ChangeLog (no dated API changelog; the
  newsroom is a press-release feed, not release notes); RateLimits (no limit published and no rate-limit headers observed);
  TermsOfService (no terms page exists on the site); and Postman, Pricing, SignUp, Login, Roadmap, Documentation, DeveloperPortal,
  APIReference, GettingStarted, CLI, Sandbox, Components and GitHubOrganization, none of which the company publishes. The
  Support pointer is the general corporate contact form — there is no developer support channel.'
x-enrichment:
  date: '2026-08-02'
  status: enriched
  artifacts_added: 16
  pass: local-v1